
Accor SA
PAR:AC


to continue AC research
to continue AC research
You've reached your weekly stock limit.
Sign UpAccor SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
32.47
50.46
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Accor SA hold over its rivals?
What risks and challenges
does Accor SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Accor SA.
Provide an overview of the primary business activities
of Accor SA.
What unique competitive advantages
does Accor SA hold over its rivals?
What risks and challenges
does Accor SA face in the near future?
Has there been any significant insider trading activity
in Accor SA recently?
Summarize the latest earnings call
of Accor SA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Accor SA.
Provide P/S
for Accor SA.
Provide P/E
for Accor SA.
Provide P/OCF
for Accor SA.
Provide P/FCFE
for Accor SA.
Provide P/B
for Accor SA.
Provide EV/S
for Accor SA.
Provide EV/GP
for Accor SA.
Provide EV/EBITDA
for Accor SA.
Provide EV/EBIT
for Accor SA.
Provide EV/OCF
for Accor SA.
Provide EV/FCFF
for Accor SA.
Provide EV/IC
for Accor SA.
Show me price targets
for Accor SA made by professional analysts.
What are the Revenue projections
for Accor SA?
How accurate were the past Revenue estimates
for Accor SA?
What are the Net Income projections
for Accor SA?
How accurate were the past Net Income estimates
for Accor SA?
What are the EPS projections
for Accor SA?
How accurate were the past EPS estimates
for Accor SA?
What are the EBIT projections
for Accor SA?
How accurate were the past EBIT estimates
for Accor SA?
Compare the revenue forecasts
for Accor SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Accor SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Accor SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Accor SA compared to its peers.
Compare the P/E ratios
of Accor SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Accor SA with its peers.
Analyze the financial leverage
of Accor SA compared to its main competitors.
Show all profitability ratios
for Accor SA.
Provide ROE
for Accor SA.
Provide ROA
for Accor SA.
Provide ROIC
for Accor SA.
Provide ROCE
for Accor SA.
Provide Gross Margin
for Accor SA.
Provide Operating Margin
for Accor SA.
Provide Net Margin
for Accor SA.
Provide FCF Margin
for Accor SA.
Show all solvency ratios
for Accor SA.
Provide D/E Ratio
for Accor SA.
Provide D/A Ratio
for Accor SA.
Provide Interest Coverage Ratio
for Accor SA.
Provide Altman Z-Score Ratio
for Accor SA.
Provide Quick Ratio
for Accor SA.
Provide Current Ratio
for Accor SA.
Provide Cash Ratio
for Accor SA.
What is the historical Revenue growth
over the last 5 years for Accor SA?
What is the historical Net Income growth
over the last 5 years for Accor SA?
What is the current Free Cash Flow
of Accor SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Accor SA.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
FR |
![]() |
Accor SA
PAR:AC
|
10.7B EUR | 11.7 | |
US |
![]() |
Booking Holdings Inc
NASDAQ:BKNG
|
186.2B USD | 21.9 |
|
MY |
G
|
Grand Central Enterprises Bhd
KLSE:GCE
|
643.2B MYR | -28 528.1 |
|
CN |
H
|
H World Group Ltd
BMV:HTHTN
|
2.7T MXN | 155.3 |
|
US |
![]() |
Airbnb Inc
NASDAQ:ABNB
|
84.5B USD | 28.4 |
|
US |
![]() |
Royal Caribbean Cruises Ltd
NYSE:RCL
|
84B USD | 17.1 |
|
US |
![]() |
Marriott International Inc
NASDAQ:MAR
|
75.2B USD | 19.9 |
|
US |
![]() |
Hilton Worldwide Holdings Inc
NYSE:HLT
|
63.4B USD | 29 |
|
CN |
![]() |
Trip.com Group Ltd
HKEX:9961
|
300.3B HKD | 19.2 |
|
US |
![]() |
Carnival Corp
NYSE:CCL
|
35.7B USD | 9.4 |
|
UK |
![]() |
Carnival PLC
LSE:CCL
|
23.4B GBP | 387.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
FR |
![]() |
Accor SA
PAR:AC
|
Average EV/EBITDA:
70
11.7
|
10%
|
1.2 | |
US |
![]() |
Booking Holdings Inc
NASDAQ:BKNG
|
21.9
|
12%
|
1.8 |
|
MY |
G
|
Grand Central Enterprises Bhd
KLSE:GCE
|
Negative Multiple: -28 528.1 | N/A | N/A |
|
CN |
H
|
H World Group Ltd
BMV:HTHTN
|
155.3
|
10%
|
15.5 |
|
US |
![]() |
Airbnb Inc
NASDAQ:ABNB
|
28.4
|
28%
|
1 |
|
US |
![]() |
Royal Caribbean Cruises Ltd
NYSE:RCL
|
17.1
|
13%
|
1.3 |
|
US |
![]() |
Marriott International Inc
NASDAQ:MAR
|
19.9
|
12%
|
1.7 |
|
US |
![]() |
Hilton Worldwide Holdings Inc
NYSE:HLT
|
29
|
20%
|
1.5 |
|
CN |
![]() |
Trip.com Group Ltd
HKEX:9961
|
19.2
|
19%
|
1 |
|
US |
![]() |
Carnival Corp
NYSE:CCL
|
9.4
|
7%
|
1.3 |
|
UK |
![]() |
Carnival PLC
LSE:CCL
|
387.8
|
8%
|
48.5 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.